Daguil, Fe O.
HRN: 27-37-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2025
CIPROFLOXACIN 500MG (TAB)
06/23/2025
06/30/2025
PO
500mg
BID
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: